Rotarix Purple Book BLA 125265

BLA number
125265
Proprietary names
Rotarix
Proper names
Rotavirus Vaccine, Live, Oral
Applicant
GlaxoSmithKline Biologicals
Center
CBER
First observed release
2020-08-01
Latest observed release
2026-06-01
Newest archive release
2026-06-01
FDA patent list
No patents listed in the captured FDA patent list; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001RotarixRotavirus Vaccine, Live, Oral351(a)1MLFor SuspensionOralSingle-Dose VialDiscLicensed2008-04-03
002RotarixRotavirus Vaccine, Live, Oral351(a)106.0CCID50SuspensionOralTubeDiscLicensed2022-11-04
003RotarixRotavirus Vaccine, Live, Oral351(a)106.0CCID50SuspensionOralOral ApplicatorRxLicensed2022-11-04

Published Patent List#

No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2024-12-01U002Rotarix351(a)DiscGlaxoSmithKline Biologicals
2024-04-01U001Rotarix351(a)DiscGlaxoSmithKline Biologicals
2022-11-01N002Rotarix351(a)RxGlaxoSmithKline Biologicals
2022-11-01N003Rotarix351(a)RxGlaxoSmithKline Biologicals
2021-05-01U001Rotarix351(a)RxGlaxoSmithKline Biologicals
2020-08-01R, U001Rotarix351(a)RxGlaxoSmithKline Biologicals

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2024-12-01002Rotarix351(a)DiscLicensed2022-11-04
2024-04-01001Rotarix351(a)DiscLicensed2008-04-03
2022-11-01002Rotarix351(a)RxLicensed2022-11-04
2022-11-01003Rotarix351(a)RxLicensed2022-11-04
2020-08-01001Rotarix351(a)RxLicensed2008-04-03